Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Colin Garner

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Antimicrobial Agents and Chemotherapy|June 5, 2019
Evaluation of a Library of FDA-Approved Drugs for Their Ability To Potentiate Antibiotics against Multidrug-Resistant Gram-Negative PathogensCharlotte K Hind, Christopher G Dowson, J Mark Sutton, et al.
Clinical Pharmacology and Therapeutics|September 6, 2006
Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugsGraham Lappin, Wilhelm Kuhnz, Roeline Jochemsen, et al.
International Journal of Cancer|September 8, 2004
Vegetable, fruit and meat consumption and potential risk modifying genes in relation to colorectal cancerFaye Turner, Gillian Smith, Christoph Sachse, et al.
British Journal of Clinical Pharmacology|June 16, 2009
A pharmacokinetic evaluation of five H(1) antagonists after an oral and intravenous microdose to human subjectsAjay Madan, Zhihong O'Brien, Jianyun Wen, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2002
Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancerGillian Smith, Francis A Carey, Julie Beattie, et al.
British Journal of Clinical Pharmacology|January 22, 2003
Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolismChristoph Sachse, Upinder Bhambra, Gillian Smith, et al.
Cancer Research|December 18, 2003
Tamoxifen DNA damage detected in human endometrium using accelerator mass spectrometryElizabeth A Martin, Karen Brown, Margaret Gaskell, et al.
British Journal of Clinical Pharmacology|July 4, 2019
Dose-linearity of the pharmacokinetics of an intravenous [<sup>14</sup> C]midazolam microdose in childrenBianca D van Groen, Wouter H Vaes, B Kevin Park, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Antimicrobial Agents and Chemotherapy|June 5, 2019
Evaluation of a Library of FDA-Approved Drugs for Their Ability To Potentiate Antibiotics against Multidrug-Resistant Gram-Negative PathogensCharlotte K Hind, Christopher G Dowson, J Mark Sutton, et al.
Clinical Pharmacology and Therapeutics|September 6, 2006
Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugsGraham Lappin, Wilhelm Kuhnz, Roeline Jochemsen, et al.
International Journal of Cancer|September 8, 2004
Vegetable, fruit and meat consumption and potential risk modifying genes in relation to colorectal cancerFaye Turner, Gillian Smith, Christoph Sachse, et al.
British Journal of Clinical Pharmacology|June 16, 2009
A pharmacokinetic evaluation of five H(1) antagonists after an oral and intravenous microdose to human subjectsAjay Madan, Zhihong O'Brien, Jianyun Wen, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2002
Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancerGillian Smith, Francis A Carey, Julie Beattie, et al.
British Journal of Clinical Pharmacology|January 22, 2003
Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolismChristoph Sachse, Upinder Bhambra, Gillian Smith, et al.
Cancer Research|December 18, 2003
Tamoxifen DNA damage detected in human endometrium using accelerator mass spectrometryElizabeth A Martin, Karen Brown, Margaret Gaskell, et al.
British Journal of Clinical Pharmacology|July 4, 2019
Dose-linearity of the pharmacokinetics of an intravenous [<sup>14</sup> C]midazolam microdose in childrenBianca D van Groen, Wouter H Vaes, B Kevin Park, et al.
Pageof 2